Logo image of SNNA

SIENNA BIOPHARMACEUTICALS INC (SNNA) Stock Price, Quote, News and Overview

NASDAQ:SNNA - Nasdaq -

0.1358  +0.03 (+34.46%)

After market: 0.146 +0.01 (+7.51%)

SNNA Quote, Performance and Key Statistics

SIENNA BIOPHARMACEUTICALS INC

NASDAQ:SNNA (12/16/2019, 8:00:01 PM)

After market: 0.146 +0.01 (+7.51%)

0.1358

+0.03 (+34.46%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High3.8
52 Week Low0.06
Market Cap4.20M
Shares30.91M
Float13.56M
Yearly Dividend0
Dividend Yield0%
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


SNNA short term performance overview.The bars show the price performance of SNNA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

SNNA long term performance overview.The bars show the price performance of SNNA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SNNA is 0.1358 null. In the past month the price decreased by -35.33%. In the past year, price decreased by -95.04%.

SIENNA BIOPHARMACEUTICALS INC / SNNA Daily stock chart

About SNNA

Company Profile

Sienna Biopharmaceuticals Inc. is a medical dermatology and aesthetics company. It provides products for inflammatory skin diseases, tissue injury and unwanted light-pigmented hair reduction. The company operates primarily in the United States and Italy. Sienna Biopharmaceuticals Inc. is based in Westlake Village, United States.

Company Info

SIENNA BIOPHARMACEUTICALS INC

30699 Russell Ranch Road Suite 140

Westlake Village CA 91362

CEO: Frederick C. Beddingfield III

Phone: 818-629-2256

SIENNA BIOPHARMACEUTICALS INC / SNNA FAQ

What is the stock price of SIENNA BIOPHARMACEUTICALS INC today?

The current stock price of SNNA is 0.1358 null. The price increased by 34.46% in the last trading session.


What is the ticker symbol for SIENNA BIOPHARMACEUTICALS INC stock?

The exchange symbol of SIENNA BIOPHARMACEUTICALS INC is SNNA and it is listed on the Nasdaq exchange.


On which exchange is SNNA stock listed?

SNNA stock is listed on the Nasdaq exchange.


What is SIENNA BIOPHARMACEUTICALS INC worth?

SIENNA BIOPHARMACEUTICALS INC (SNNA) has a market capitalization of 4.20M null. This makes SNNA a Nano Cap stock.


What are the support and resistance levels for SIENNA BIOPHARMACEUTICALS INC (SNNA) stock?

SIENNA BIOPHARMACEUTICALS INC (SNNA) has a resistance level at 0.17. Check the full technical report for a detailed analysis of SNNA support and resistance levels.


Should I buy SIENNA BIOPHARMACEUTICALS INC (SNNA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SIENNA BIOPHARMACEUTICALS INC (SNNA) stock pay dividends?

SNNA does not pay a dividend.


What is the Price/Earnings (PE) ratio of SIENNA BIOPHARMACEUTICALS INC (SNNA)?

SIENNA BIOPHARMACEUTICALS INC (SNNA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.03).


SNNA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SNNA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SNNA. SNNA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SNNA Financial Highlights

Over the last trailing twelve months SNNA reported a non-GAAP Earnings per Share(EPS) of -2.0300000000000002. The EPS increased by 37.15% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -110.25%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%80.49%
Sales Q2Q%N/A
EPS 1Y (TTM)37.15%
Revenue 1Y (TTM)N/A

SNNA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 100% to SNNA. The Buy consensus is the average rating of analysts ratings from 2 analysts.


Ownership
Inst Owners17.36%
Ins Owners8.32%
Short Float %N/A
Short RatioN/A
Analysts
Analysts100
Price TargetN/A
EPS Next Y13.65%
Revenue Next YearN/A